| Members |
targetComponentId |
| Phialophora richardsiae |
Pleurostomophora richardsiae (organism) |
| Philadelphia chromosome positive chronic myelogenous leukemia |
Chronic myeloid leukemia |
| Phocanema decipiens |
Pseudoterranova decipiens |
| pholcolin |
Pholcodine (substance) |
| Phosphocol, p-32 15 mCi injektionsvæske, suspension, hætteglas a 10 ml |
Chromic phosphate (32-P) only product in parenteral dose form |
| phospholipasespecifikt ekstrakt |
Product containing phospholipase (medicinal product) |
| fosfolipid 35 mg + protein 0,65 mg suspension |
Product containing only calfactant (medicinal product) |
| Phosphoric diester hydrolase |
Phosphoric diester hydrolase |
| Phosphoric monoester hydrolase |
Phosphoric monoester hydrolase |
| phosphor-32 (diagnostisk) |
Product containing phosphorus-32 (medicinal product) |
| Phosphorus-oxygen lyase |
Phosphorus-oxygen lyase |
| Phosphotransferase |
Kinase |
| Photocoagulation of lesion of retina NEC |
Destruction of lesion of retina by photocoagulation |
| Photocoagulation of retina for detachment NOS |
Repair of retinal detachment by photocoagulation (procedure) |
| Photographer/cameraman NOS |
Photographer AND/OR cameraman |
| Photographer/cameraman NOS |
Photographer AND/OR cameraman |
| Photoptarmosis |
Photoptarmosis |
| Photorhabdus luminescens subsp. thracensis |
Photorhabdus temperata subspecies thracensis (organism) |
| Photosensitising drugs |
A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. |
| Phototherapy &/or radiation therapy |
Radiotherapy |
| phthatalat anhydrid-specifikt ekstrakt |
Phthalic anhydride |
| Thermomicrobia |
Class Thermomicrobia (organism) |
| Phylum acanthocephala |
Phylum Acanthocephala (organism) |
| rækken Microspora |
Phylum Microsporidia (organism) |
| Physical examination - action |
Examination - action |
| Physical exercise NOS |
Physical exercises (regime/therapy) |
| Physical exercise NOS |
Physical exercises (regime/therapy) |
| Physical medicine iontophoresis |
An administration into the tissues of an ionic substance by means of an electric current |
| fysiurgisk behandling |
Physical medicine service (qualifier value) |
| Physical science technician |
Physics technician |
| Physical scientist NOS |
Physical scientist |
| Physical scientist NOS |
Physical scientist |
| Physical/nutrit. assess NOS |
Assessment of nutritional status |
| Physical/nutrit. assess NOS |
Assessment of nutritional status |
| lægebehandling |
Physician service (qualifier value) |
| Physics - other therapy |
Therapy |
| Physics - other therapy |
Therapy |
| Physics - other therapy NOS |
Therapy |
| Physics - other therapy NOS |
Therapy |
| Physics-other measurements NOS |
Physics - other measurements |
| Physics-other measurements NOS |
Physics - other measurements |
| Physics: diagn. methods NOS |
Determination of a value, conclusion, or inference by evaluating evidence |
| Physics: diagnostic methods NOS |
Determination of a value, conclusion, or inference by evaluating evidence |
| Physics: other diagn. methods |
Determination of a value, conclusion, or inference by evaluating evidence |
| Physics: other diagnostic methods |
Determination of a value, conclusion, or inference by evaluating evidence |
| Physiol. function test NOS |
Physiological function tests |
| Physiol. function test NOS |
Physiological function tests |
| Fysiologiske funktioner og aktiviteter |
Functional status document section (record artifact) |
| Physiological jaundice (& [NOS]) |
Newborn physiological jaundice |
| physostigmin 0,25 % øjendråber |
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| physostigmin 0,5 % øjendråber |
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| physostigmin 0,25 % + pilocarpin 2 % øjendråber |
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution |
| physostigmin 0,25 % + pilocarpin 4 % øjendråber |
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
| physostigmin 0,5 % + pilocarpin 4 % øjendråber |
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Pichia ohmeri |
Kodamaea ohmeri (organism) |
| Pick's cell |
Niemann-Pick cell |
| Picornavirus |
Family Picornaviridae (organism) |
| Pigeon droppings protein |
Pigeon droppings |
| pigmentnævus |
Pigmented nevus |
| pigmenteret hudlæsion med mistanke om malign art |
Suspected malignant pigmented skin lesion (situation) |
| Pigmented villonodular synovitis |
Diffuse tenosynovial giant cell tumor |
| pigmenteret villonodulær synovit |
Diffuse tenosynovial giant cell tumor |
| pigmenteringsmiddel |
Pigment |
| Pigmenteringsmiddel |
Pigment |
| pilocarpinhydrochlorid 10 % øjendråber |
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Pilocarpine hydrochloride 5.0mg tablet |
Product containing precisely pilocarpine hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
| Pilocarpine nitrate 1% conventional release eye drops |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
| pilocarpinnitrat 1 % øjendråber til engangsbrug |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
| Pilocarpine nitrate 2% conventional release eye drops |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
| pilocarpinnitrat 2 % øjendråber til engangsbrug |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
| Pilocarpine nitrate 4% conventional release eye drops |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
| pilocarpinnitrat 4 % øjendråber til engangsbrug |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
| Pilocarpine nitrate 4% single-use eye drops |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
| Pilocytic astrocytoma |
Pilocytic astrocytoma |
| Pilonidal cyst with no abscess |
Pilonidal cyst |
| lyserød farve |
Pink color (qualifier value) |
| Pioglitazone 15mg + metformin 1g m/r tablet |
Metformin and pioglitazone only product in oral dose form |
| Pioglitazone 15mg + metformin 1g prolonged-release oral tablet |
Metformin and pioglitazone only product in oral dose form |
| Pioglitazone 30mg + metformin 1g m/r tablet |
Metformin and pioglitazone only product in oral dose form |
| Pioglitazone 30mg + metformin 1g prolonged-release oral tablet |
Metformin and pioglitazone only product in oral dose form |
| Pipe/sheet metal worker NOS |
Pipe/sheet/structural metal worker |
| Pipe/sheet metal worker NOS |
Pipe/sheet/structural metal worker |
| piperacillin 1 g pulver til injektionsvæske, opløsning, hætteglas |
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| piperacillin 2 g pulver til injektionsvæske, opløsning, hætteglas |
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial |
| Piperacillin 3g injection (pdr for recon) |
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
| Piperacillin 4g infusion set |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
| piperacillin 4 g pulver til injektionsvæske, opløsning, hætteglas |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
| piperacillin 4 g/tazobactam 500 mg pulver og solvens til infusionsvæske, hætteglas |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Piperacillin sodium + tazobactam sodium ns/ns injection |
Product containing piperacillin and tazobactam (medicinal product) |
| piperacillinnatrium 3 g pulver til injektionsvæske, opløsning, hætteglas |
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
| piperacillinnatrium 4 g pulver til injektionsvæske, opløsning, hætteglas |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
| piperazin 4 g + sennosider 15,3 mg oralt pulver i brev |
Product containing only piperazine and sennoside (medicinal product) |
| bivirkning af piperidolathydrochlorid |
Adverse reaction to piperidolate (disorder) |
| Piple cumanesis cumanesis |
Aburria cumanensis subspecies cumanensis (organism) |
| pirbuterolacetat 0,2 mg aerosol |
Product containing only pirbuterol (medicinal product) |
| Piringers lymfadenit |
Lymphadenitis caused by Toxoplasma gondii (disorder) |
| Piringer-Kuchinkas syndrom |
Lymphadenitis caused by Toxoplasma gondii (disorder) |
| Piringer-Kuchinka's syndrome |
Lymphadenitis caused by Toxoplasma gondii (disorder) |
| piroxicam 10 mg dispergibel tablet |
Piroxicam 10 mg oral tablet |
| Piroxicam 20mg conventional release orodispersible tablet |
Piroxicam 20 mg oral tablet |
| piroxicam 20 mg dispergibel tablet |
Piroxicam 20 mg oral tablet |
FHIR